Prospective study to examine the polyp detection rate positive effect by colonoscopy using Endocuff, and small intestinal transit time shortening effect of Niflec versus Moviprep in colon capsule endoscopy.
Not Applicable
- Conditions
- The patient who have colonoscopy.
- Registration Number
- JPRN-UMIN000012385
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who may have been stenosed or occluded lesion of gastrointestinal tract. 2. Patients who have been diagnosed from the beginning that there is a colon lesion. 3. Patients who may have been lower gastrointestinal tract diseases such as melena and diarrhea. 4. Patients with severe renal failure, liver failure, circulatory failure. 5. Patients who are pregnant, suspected to be pregnant or breastfeeding. 6. Patients with drug allergy and/or history of severe side effects due to analgesic and/or sedatives. 7. Patients who are judged to be difficult treatment for complications. 8. Stop of this study. 9. Patients who are considered to be inapproriate by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Transit time of total tract of the colon capsule endoscope (small intestine transit time). 2. Positive effect of polyp detection rate by colonoscopy using Endocuff.
- Secondary Outcome Measures
Name Time Method